Pharsight

IMPAX LABORATORIES LLC PATENTS FACING OPPOSITIONS

Top patents of IMPAX LABORATORIES LLC facing oppositions at the European Patent Office (EPO)

Patent Number Grant Date Patent Title Expected Expiration Date Facing Oppositions Activity Alert
EP2234963B1 08 Apr, 2020 Controlled Release Formulations Of Levodopa And Uses Thereof Dec, 2028 2
EP3054929B1 05 Aug, 2020 Muco-Adhesive, Controlled Release Formulations Of Levodopa And/Or Esters Of Levodopa And Uses Thereof Oct, 2034 1
EP3068396B1 08 May, 2019 Rapidly Disintegrating Formulations And Methods Of Use Nov, 2034 1